why choose us

First received: October 04, 2023

Clinical Trial: A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety Study of SAR441566 Plus Methotrexate in Adults With ModeratetoSevere Rheumatoid Arthritis

Brief Summary: This is a parallel group, Phase 2, randomized, double-blind, placebo controlled, 5-arm, international, multicenter, 12-week proof of concept, dose finding study.It is designed to assess efficacy and safety of treatment with SAR441566 for 12 weeks.It will be conducted in male and female adult participants with moderate-to-severe rheumatoid arthritis (RA) not adequately controlled on methotrexate (MTX) and biologic/targeted synthetic disease modifying anti-rheumatic drug (DMARD) naive.Study treatment includes…

Read more